Reaction profile

The FDA adverse-event record for pr-thyroid, lesion(s)

27 FDA reports name pr-thyroid, lesion(s), a lower-volume reaction in the CVM extract (VeDDRA 99688). Plate stamps and neighbourhood peers follow.

#2045 of 2,481
by report volume (all reactions)
27
reports citing this reaction
88.9%
death-coded share
Dog
most-affected species
Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. PR-THYROID, LESION(S) has 27 reports now versus 27 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to PR-THYROID, LESION(S) changes

FDA AER · VeDDRA plate

Code 99688 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 27 reports
  • DEATH-HOT 88.9%
  • LOWER-Q #2045/2481
  • PHOTO-FINISH Abortion spontaneous
  • SPECIES-DOG Dog · 17
  • DRUG-LEAD Cefovecin · 4
  • DESK-WIDE 16 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Abortion spontaneous (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around PR-THYROID, LESION

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Abortion spontaneous · near27Aplastic anaemia · near27Cyanotic spots/blotch… · near27Cyst rupture NOS · near27PR-THYROID, LESION(S) · this…27Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around PR-THYROID, LESION(S)

PR-THYROID, LESION(S): high death-coded share in the FDA AER plate

Signature read: PR-THYROID, LESION(S)'s 88.9% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 27 named reports in the openFDA extract. Death-coded share is upper-third: 24 of 27 reports (88.9% of named reports). Nearest volume peer: Abortion spontaneous (±0 reports). Lead species Dog (17). Lead co-reported drug Cefovecin (4).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 17
Cat 9
Horse 1

Breeds Most Affected

Domestic (unspecified) 4
Domestic Shorthair 4
Crossbred Canine/dog 2
Doberman Pinscher 2
Beagle 2
Retriever - Labrador 2
Boxer (German Boxer) 2
Newfoundland 1
Persian 1
Pointing Dog - Hungarian Short-haired (Vizsla) 1

Associated Drugs

Cefovecin 4
Oclacitinib Maleate 4
Milbemycin Oxime + Spinosad 3
Spinosad 2
Robenacoxib 2
Carprofen 2
Levothyroxine Sodium 2
Fluralaner Chew Tablets 2
Dexmedetomidine Hydrochloride 1
Selamectin 1
Deracoxib 1
Cefovecin Sodium 1
Antibiotic (Unknown) 1
Ticarcillin Disodium, Clavulanate Potassium 1
Dexamethasone 1
Food 1
Methimazole 1
Imidacolprid And Moxidectin 1
Methylprednisolone Acetate 1
Dhpp Vaccine 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for PR-THYROID, LESION(S) (#2045 of 2,481 by report volume); death-coded 88.9%. PlainBreed reaction plate · death-coded share stamp 88.9% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →